← Eichor
Study identifier: NCT06980688 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The PROTECT Trial: PROpofol Titration to Enhance haemodynamiC sTability

Condition: Anesthesia  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseNA
Planned participants320
Who can joinAll sexes, 55 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this multicentre, single-blinded, expertise-based randomised controlled trial is evaluate whether slowly increasing the dose of the anaesthetic drug propofol based on a patient's needs leads to more stable blood pressure compared to giving a standard starting dose in patients aged 55 and older undergoing non-cardiac surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Martin Lohri, Dr. med.  ·  +41 61 556 52 27  ·  martindominik.lohri@usb.ch

Always discuss trial participation with your own doctor first.

Locations (4)

Kantonsspital BadenBaden, SwitzerlandNot Yet Recruiting
University Hospital BaselBasel, SwitzerlandRecruiting
Cantonal Hospital GraubündenChur, SwitzerlandNot Yet Recruiting
Kantonsspital Olten, soHOlten, SwitzerlandNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06980688